ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
72 hedge funds and large institutions have $273M invested in Albireo Pharma, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 1 closing their positions.
Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
26
Reduced
20
Closed
1
Calls
$193K
Puts
$412K
Net Calls
-$219K
Net Calls Change
-$170K
Top Buyers
Top Sellers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$13.5M |
2 |
2
Renaissance Technologies
New York
|
$787K |
3 |
3
Morgan Stanley
New York
|
$70K |
4 |
4
BlackRock
New York
|
$18.5M |
5 |
5
Victory Capital Management
San Antonio,
Texas
|
$2.04M |